Skip to Content


In the US, Moexipril (moexipril systemic) is a member of the drug class angiotensin converting enzyme inhibitors and is used to treat Diabetic Kidney Disease, Heart Attack, Heart Failure, High Blood Pressure and Left Ventricular Dysfunction.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

ACE inhibitor (angiotensin-converting enzyme inhibitor)

Antihypertensive agent

Chemical Name

(3S)-2-[(2S)-N-[(1S)-1-Carboxy-4-phenylpropyl]alanyl]-1,2,3,4-tetrahydro-6,7-dimethoxy-3-isoquinolinecarboxylic acid, 2-ethyl ester

Foreign Names

  • Moexiprilum (Latin)
  • Moexipril (German)
  • Moexipril (French)
  • Moexipril (Spanish)

Generic Names

  • Moexipril (OS: BAN, DCF)
  • RS 10085 (IS: Syntex)
  • Moexipril Hydrochloride (OS: USAN, BANM)
  • CI 925 (IS)
  • RS 10085-197 (IS: Syntex)
  • SPM 925 (IS)

Brand Names

International Drug Name Search


BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.